JayOBoyleMD

Otolaryngology (ENT) • Basking Ridge, NJ

Head & Neck Oncologic Surgery

Associate Professor, Otolaryngology , Head & Neck Surgery, Weill Cornell Medical College

Overview of Dr. Boyle

Dr. Jay Boyle is an otolaryngologist in Basking Ridge, NJ and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and NYC Health + Hospitals / Bellevue. He received his medical degree from University of Arizona College of Medicine-Tucson and has been in practice 31 years. Dr. Boyle accepts several types of health insurance, listed below. He is one of 21 doctors at Memorial Sloan Kettering Cancer Center and one of 45 doctors at NYC Health + Hospitals / Bellevue who specialize in Otolaryngology (ENT). He has more than 90 publications and over 500 citings.

Office
136 Mountain View Boulevard
Basking Ridge, NJ 07920
Book by Phone+1(209) 546-6331

Education & Training

Johns Hopkins UniversityResidency, Otolaryngology - Head and Neck Surgery, 1992 - 1996
Johns Hopkins UniversityInternship, Otolaryngology - Head and Neck Surgery, 1991 - 1992
University of Arizona College of MedicineClass of 1990

Certifications & Licensure

NY State Medical License 1996 - 2026
NJ State Medical License 2007 - 2025
MD State Medical License 1992 - 1996
American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2012-2014
Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery

Clinical Trials

Celecoxib in Treating Patients With Precancerous Lesions of the Mouth Start of enrollment: 2000 Oct 01
Completed
Phase 2
A Randomized Study of Sulindac in Oral Premalignant Lesions Start of enrollment: 2006 Feb 23
Completed
Not Applicable
Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia Start of enrollment: 2006 Jun 01
Completed
Phase 2
Erlotinib Prevention of Oral Cancer (EPOC) Start of enrollment: 2006 Nov 03
Completed
Phase 3
Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma Start of enrollment: 2003 Dec 01
Completed
Not Applicable
Biomarkers of Molecular Risk in Smokers Start of enrollment: 2005 Feb 01
Completed
Pioglitazone for Oral Premalignant Lesions Start of enrollment: 2010 Feb 01
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

11 citations
Hypoxia-Directed Treatment of Human Papillomavirus-Related Oropharyngeal Carcinoma.
Nancy Y Lee, Eric J Sherman, HeiKo Schöder, Rick Wray, Jay O Boyle
Journal of Clinical Oncology. 2024-03-10
567 citations
Molecular Assessment of Histopathological Staging in Squamous-Cell Carcinoma of the Head and Neck
Joseph Brennan, Li Mao, Ralph H. Hruban, Jay O. Boyle, Yolanda Eby
The New England Journal of Medicine. 1995-02-16
28 citations
Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus-associated oropharyngeal cancer.
Jung Julie Kang, Yao Yu, Linda Chen, Kaveh Zakeri, Daphna Yael Gelblum
CA. 2023-03-01

Press Mentions

New MSK Radiation Approach Means Fewer Side Effects for More Patients with HPV-Related Head and Neck CancerJanuary 20th, 2022

Professional Memberships

American Academy of Otolaryngology - Head and Neck Surgery - AAO - NHS
Fellow

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Cofinity PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
PriorityHealth HMO
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment